In 2013, the EU-guidelines on GDP of Medicinal Products for Human Use have been augmented: Now for example, the required storage conditions of pharmaceuticals are to be maintained during transportation. In addition, new requirements apply concerning cleanliness and security of any intermediate storage facility. Although increasing complexity these specifications create space for opportunities such as differentiation or benefit from cost advantage over competition.